From the first report in 2006, describing a loss-of-function mutation in the gene encoding the filament aggregating protein filaggrin (FLG), the role of FLG in the barrier-based pathogenesis of AD has been extensively researched [2,4]. Here, FLG is linked to Alzheimer disease.